PA9-26355-19665
5 vaccinations
1 coded response
37 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 240 / VA
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-16
Dose 1 — Pfizer-BioNTech
-
2020-12-17
Registered in v-safe
-
2020-12-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Nausea, DiarrheaAdult check-in
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-25
- 2020-12-30
-
2021-01-06
Dose 2 — Pfizer-BioNTech
-
2021-01-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-20
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-04-07
- 2021-07-07
-
2021-10-06
Dose 3 — Pfizer-BioNTech
-
2022-01-06
Survey response — 12 months, dose 2MedDRA: Anembryonic gestation, Medical procedure, Office visit, Pregnancy, Uterine dilation and curettage — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Pregnancy, anembryonic, required d&c October 15, 2021. Now pregnant again, estimated due date August 24, 2022. · Healthcare visit (other): Outpatient procedureMedDRA releases: 2024-11 · check-in free text available
-
2022-01-06
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-07
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-07-14
Dose 4 — Moderna
-
2022-10-04
Dose 5 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-05
- 2022-10-06
- 2022-10-07
- 2022-10-08
- 2022-10-09
- 2022-10-10
- 2022-10-11
- 2022-10-18
- 2022-10-25
- 2022-11-01
- 2022-11-08
- 2022-11-15
- 2023-01-03
- 2023-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-06 | Pfizer-BioNTech | |
| 3 | 2021-10-06 | Pfizer-BioNTech | No |
| 4 | 2022-07-14 | Moderna | No |
| 5 | 2022-10-04 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-06 | Successful 2022-01-07 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 10 — 12 months, dose 2
Symptoms: Pregnancy, anembryonic, required d&c October 15, 2021. Now pregnant again, estimated due date August 24, 2022.
Healthcare visit (other): Outpatient procedure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical procedure | · | · | ✓ |
| HCVO | Office visit | · | · | ✓ |
| SD | Anembryonic gestation | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Uterine dilation and curettage | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release